Akèy › Maladi fwa steatotik › Illinois › Chicago

Etid klinik pou Maladi fwa steatotik nan Chicago, IL

6 etid pou Maladi fwa steatotik ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Ap rekriteFaz 3

89bio Clinical Study Site, Chicago

Laj 18 a 75 · Tout sèks · Mizajou Oct 5, 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Ap rekriteFaz 3

89bio Clinical Study Site, Chicago

Laj 18 a 80 · Tout sèks · Mizajou Oct 5, 2026 · NCT06318169

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Ap rekriteFaz 3

University of Chicago Medical Center, Chicago

Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Ap rekriteFaz 3

Akero Clinical Study Site, Chicago

Laj 18 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT06528314

Non-Invasive Quantification of Liver Health in NASH (N-QUAN)

Ap rekrite

RUSH University Medical Center, Chicago

Laj 18 a 75 · Tout sèks · Mizajou May 19, 2026 · NCT04054310

Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease

Ap rekriteFaz 2

Ann & Robert H Lurie Children's Hospital of Chicago, Chicago

Laj 16 a 20 · Tout sèks · Mizajou Jan 21, 2026 · NCT06355310

Etid Maladi fwa steatotik nan lòt vil

Lòt etid nan Chicago

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.